Sign in
8-K

Current Report

Cocrystal Pharma, Inc. Filed Acc 0001521536-13-000295

Material agreement · New debt or obligation

  • Item 1.01 Entry into a material definitive agreement
  • Item 2.03 Creation of a direct financial obligation

From the SEC's structured data for this filing

Loading q1101046_8k-biozone.htm…